Jaguar Health, Inc. Business Finance Contracts & Agreements
166 Contracts & Agreements
- Assignment Agreements (2 contracts)
- Credit Agreements (3)
- Escrow Agreements (1)
- Exchange Agreements (8)
- Financing Agreements (1)
- Guaranty Agreements (1)
- Investor Rights Agreements (2)
- Loan Agreements (3)
- Note Agreements (27)
- Purchase Agreements (27)
- Registration Rights Agreements (9)
- Security Agreements (9)
- Share Agreements (2)
- Stock Agreements (18)
- Subordination Agreement (2)
- Subscription Agreements (1)
- Underwriting Agreements (7)
- Warrant Agreements (43)
- Exchange Agreement, dated September 29, 2023, by and between Jaguar Health, Inc. and Uptown Capital, LLC (Filed With SEC on October 5, 2023)
- Form of Warrant (Filed With SEC on October 5, 2023)
- Form of Exchange Agreement (Filed With SEC on July 3, 2023)
- Form of Securities Purchase Agreement (Filed With SEC on May 9, 2023)
- Form of Warrant (Filed With SEC on May 9, 2023)
- Form of Company Stock Option Cancellation Agreement (Filed With SEC on December 30, 2022)
- Securities Purchase Agreement, dated November 11, 2022, by and between Jaguar Health, Inc. and SynWorld Technologies Corporation (Filed With SEC on November 16, 2022)
- Royalty Interest Purchase Agreement, dated August 24, 2022, by and between Jaguar Health, Inc. and Streeterville Capital, LLC (Filed With SEC on August 30, 2022)
- Securities Purchase Agreement, dated August 18, 2022, by and between Jaguar Health, Inc. and SynWorld Technologies Corporation (Filed With SEC on August 23, 2022)
- Securities Purchase Agreement, dated September 13, 2021, by and between Jaguar Health, Inc. and the investors named therein (Filed With SEC on September 17, 2021)
- Subscription Agreement, dated June 1, 2021, by and among Dragon SPAC S.p.A., Napo Pharmaceuticals, Inc. and Joshua Mailman (Filed With SEC on June 4, 2021)
- Form of Securities Purchase Agreement (Filed With SEC on April 30, 2021)
- Registration Rights Agreement, dated April 7, 2021, between Jaguar Health, Inc. and Oasis Capital, LLC (Filed With SEC on April 8, 2021)
- First Amendment to the Equity Purchase Agreement, dated April 7, 2021, between Jaguar Health, Inc. and Oasis Capital, LLC (Filed With SEC on April 8, 2021)
- Common Stock Purchase Warrant, dated April 7, 2021, between Jaguar Health, Inc. and Oasis Capital, LLC (Filed With SEC on April 8, 2021)
- Securities Purchase Agreement, dated March 8, 2021, by and between Jaguar Health, Inc. and Streeterville Capital, LLC (Filed With SEC on March 11, 2021)
- Security Agreement, dated January 19, 2021, by and between Napo Pharmaceuticals, Inc. and Streeterville Capital, LLC (Filed With SEC on January 22, 2021)
- Note Purchase Agreement, dated January 19, 2021, by and among Jaguar Health, Inc., Napo Pharmaceuticals, Inc. and Streeterville Capital, LLC (Filed With SEC on January 22, 2021)
- Secured Promissory Note, dated January 19, 2021, by and among Jaguar Health, Inc., Napo Pharmaceuticals, Inc. and Streeterville Capital, LLC (Filed With SEC on January 22, 2021)
- Form of Securities Purchase Agreement (Filed With SEC on January 14, 2021)
- Securities Purchase Agreement, dated December 22, 2020, by and between Jaguar Health, Inc. and Irving Park Capital, LLC (Filed With SEC on December 29, 2020)
- Exchange Agreement, dated October 8, 2020, by and between Jaguar Health, Inc. and Iliad Research and Trading, L.P (Filed With SEC on October 9, 2020)
- Royalty Interest Purchase Agreement, dated October 8, 2020, by and between Jaguar Health, Inc. and Iliad Research and Trading, L.P (Filed With SEC on October 9, 2020)
- Form of Pre-Funded Common Stock Purchase Warrant (Filed With SEC on October 9, 2020)
- Stock Plan Agreement, dated October 6, 2020, by and between Jaguar Health, Inc. and PoC Capital, LLC (Filed With SEC on October 7, 2020)
- Stock Plan Agreement for Payment of Consulting Services, dated September 1, 2020, by and among Jaguar Health, Inc., Sagard Capital Partners Management Corp. and Sagard Capital... (Filed With SEC on September 2, 2020)
- Exchange Agreement, dated September 1, 2020, by and between Jaguar Health, Inc. and Iliad Research and Trading, L.P (Filed With SEC on September 2, 2020)
- First Amendment to Assignment Agreement, dated June 26, 2020, by and between Napo Pharmaceuticals, Inc. and Oasis Capital, LLC (Filed With SEC on August 13, 2020)
- First Amendment to Purchase Agreement, dated June 26, 2020, by and among Jaguar Health, Inc., Napo Pharmaceuticals, Inc. and Oasis Capital, LLC (Filed With SEC on August 13, 2020)
- First Amendment to Royalty Interest Purchase Agreement and Related Documents, dated July 10, 2020, between Jaguar Health, Inc. and Iliad Research and Trading, L.P (Filed With SEC on July 14, 2020)
- Form of Notice of Grant of Restricted Stock Units and Restricted Stock Unit Agreement under the Jaguar Health, Inc. New Employee Inducement Award Plan (Filed With SEC on June 19, 2020)
- Form of Notice of Grant of Stock Option and Stock Option Agreement under the Jaguar Health, Inc. New Employee Inducement Award Plan (Filed With SEC on June 19, 2020)
- Form of Series 3 Warrant (Filed With SEC on May 22, 2020)
- Assignment Agreement, dated May 12, 2020, by and between Napo Pharmaceuticals, Inc. and Oasis Capital, LLC (Filed With SEC on May 21, 2020)
- Purchase Agreement, dated May 12, 2020, by and among Jaguar Health, Inc., Napo Pharmaceuticals, Inc. and Oasis Capital, LLC (Filed With SEC on May 21, 2020)
- Purchase Agreement, dated April 15, 2020, by and between Napo Pharmaceuticals, Inc. and Atlas Sciences, LLC (Filed With SEC on April 16, 2020)
- Landlord Letter of Credit Agreement, dated March 24, 2020, by and between Jaguar Health, Inc. and Charles Conte (Filed With SEC on March 26, 2020)
- Registration Rights Agreement, dated March 24, 2020, by and between Jaguar Health, Inc. and Oasis Capital, LLC (Filed With SEC on March 26, 2020)
- Equity Purchase Agreement, dated March 24, 2020, by and between Jaguar Health, Inc. and Oasis Capital, LLC (Filed With SEC on March 26, 2020)
- Warrant Exercise and Preferred Stock Amendment Agreement, dated March 24, 2020, by and between Jaguar Health, Inc. and the Holder named therein (Filed With SEC on March 26, 2020)
